OCGN 주가 차트
OCGN 주가 예측
Ocugen Inc
$1.49
-19.45%
$-0.36
종가: May 05, 16:00:00 GMT-4
$1.54
3.35%
$0.05
프리마켓: May 06, 07:30:14 GMT-4
뒤로
Ocugen Inc (OCGN) 주가 예측
주요 통계
이전 종가
$1.85
시가
$1.55
일일 범위
$1.48 - $1.57
52주 범위
$0.64 - $2.72
거래량
29.2M
평균 거래량
6.8M
배당수익률
--
EPS(TTM)
-0.22
시가총액
$504.9M
OCGN란 무엇인가요?
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. The company is headquartered in Malvern, Pennsylvania and currently employs 116 full-time employees. The company went IPO on 2014-12-03. Its technology pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal Vaccine Platform. The company is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal diseases, including retinitis pigmentosa, Leber congenital amaurosis, Stargardt disease and multifactorial diseases, such as dry age-related macular degeneration (dAMD) and geographic atrophy. The company is developing a next-generation, inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine, and OCU520, a combination quadrivalent seasonal flu.
